Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Rebuttals- perma bulls? KWSdeluxe? Yank your jeeber?

<< Previous

Bullboard Posts

Next >>

Comment by Kswdeluxon Jun 20, 2021 10:53pm

251 Views

Post# 33418730

RE:RE:RE:RE:RE:RE:RE:RE:RE:Rebuttals- perma bulls? KWSdeluxe? Yank your jeeber?

I listened to the Coffe interview. Thought it was great.

If you know this company and have read the NRs and have listened to the corp conference calls, etc. Over the years, Matt drops a lot of comments in there. If you are familiar with this company... you will have picked them up...it's all good and some great comments...

As noted, I think the next 6 months are going to be very interesting.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management